Advanced Medical Solutions Group (LON:AMS) Reaches New 52-Week High – What’s Next?

Advanced Medical Solutions Group plc (LON:AMS) shares reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as GBX 279.50 and last traded at GBX 278.50, with a volume of 134323438 shares. The stock had previously closed at GBX 240.

Analyst Ratings Changes

A number of brokerages have recently issued reports on AMS. Royal Bank Of Canada reiterated a “sector perform” rating and set a GBX 260 target price on shares of Advanced Medical Solutions Group in a report on Thursday, April 9th. Berenberg Bank reissued a “buy” rating and set a GBX 300 price target on shares of Advanced Medical Solutions Group in a research report on Tuesday, May 19th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of GBX 270.25.

Advanced Medical Solutions Group Trading Up 16.1%

The company has a market cap of £605.03 million, a P/E ratio of 61.62, a P/E/G ratio of 5.00 and a beta of 0.71. The business has a fifty day simple moving average of GBX 231.69 and a 200 day simple moving average of GBX 217.86. The company has a debt-to-equity ratio of 31.50, a quick ratio of 4.58 and a current ratio of 2.79.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.